SCHEMBL12149381

SCHEMBL12149381

Cc1ccc(-c2cc3c(cc2-c2ccc(C(F)(F)F)cc2)-c2cc4c(cc2C3=C(C#N)C#N)C(=C(C#N)C#N)c2cc(-c3ccc(C(F)(F)F)cc3)c(-c3ccc(C(F)(F)F)cc3)cc2-4)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.43
AR P10275 1/20 0.39
KIF11 P52732 2/20 0.39
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
XDH P47989 1/20 0.37
APP P05067 1/20 0.36
BACE1 P56817 1/20 0.35
NPBWR1 P48145 1/20 0.35
MAPT P10636 3/20 0.35
ALDH1A1 P00352 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CYP1A1 P04798 2/20 0.34
CYP1B1 Q16678 2/20 0.34
AKR1C3 P42330 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12198221 0.93 KIF11 (0.44) KDM1AKIF11PSEN1PSEN2APH1B
SCHEMBL12148949 0.91 AR (0.43) KDM1AARKIF11PSEN1PSEN2
SCHEMBL12117578 0.91 AR (0.43) KDM1AARKIF11PSEN1PSEN2
SCHEMBL12149292 0.87 AR (0.37) KDM1AARKIF11PSEN1PSEN2
SCHEMBL12149302 0.84 AR (0.42) KDM1AARKIF11PSEN1PSEN2
SCHEMBL12149373 0.83 MAPT (0.39) KIF11MAPTALDH1A1CYP1A1CYP1B1
SCHEMBL21917429 0.83 KIF11 (0.42) KDM1AARKIF11PSEN1PSEN2
SCHEMBL21917103 0.83 KIF11 (0.42) KDM1AARKIF11PSEN1PSEN2
SCHEMBL12148659 0.83 KDM1A (0.40) KDM1AARKIF11PSEN1PSEN2
SCHEMBL12149405 0.82 KIF11 (0.45) ARKIF11PSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110284827-A1 INDENOFLUORENEDIONE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110284827-A1 INDENOFLUORENEDIONE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT HSD17B11, HSD17B2, HSD17B1 KDM1A 2496/4885AR 134/4885KIF11 1128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.